This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
More aggressive secondary prevention of cardiovascular disease now funded
+Educate
In print
Cardiovascular health
More aggressive secondary prevention of cardiovascular disease now funded
Friday 1 April 2022, 12:45 AM
[Image: iStock.com – Rasi Bhadramani]
Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Key points, Rosuvastatin 40mg will lower the LDL cholesterol level by approximately 63 per cent, compared with about 55 per cent with atorvastatin 80mg.
Ezetimi, Education Blue W/ Grey Background W/ Padding
References
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):11188.